University of Minnesota Ph.D. dissertation. December 2020. Major: Pharmaceutics. Advisor: Raj Suryanarayanan. 1 computer file (PDF); xvi, 239 pages.Amorphous solid dispersions (ASDs) can improve the oral bioavailability of poorly water-soluble drugs. However, the physical instability of the amorphous form, denoted by the propensity to recrystallize, is a major barrier to the use of ASDs. The overarching goal of this thesis was to understand the mechanisms by which two major classes of additives – antiplasticizers (various polymers) and plasticizers (mainly glycerol) – affect the physical stability of amorphous formulations, in the dry solid form, as well as in aqueous solution. In the first project, we investigated the impact of the str...
Poorly water-soluble drugs pose a significant challenge in developability due to poor oral absorptio...
The formulation of oral amorphous solid dispersions (ASD) includes the use of excipients to improve ...
Amorphous formulations, including amorphous solid dispersions (ASDs), consisting of the active pharm...
University of Minnesota Ph.D. dissertation.January 2018. Major: Pharmaceutics. Advisor: Raj Suryana...
University of Minnesota Ph.D. dissertation. October 2016. Major: Pharmaceutics. Advisor: Dr. Raj Sur...
Current drug discovery techniques tend to identify potential new drug entities with more complex str...
Many pharmaceutical compounds being developed in recent years are poorly soluble in water. This has ...
Amorphous drug delivery systems are increasingly utilized to enhance aqueous solubility and oral bio...
A major concern during formulation development has been to enhance the dissolution rate and bioavail...
Over the past few decades, amorphous solid dispersions (ASDs) have been of great interest to pharmac...
Polymers are often used to stabilize amorphous drug formulations enabling the maintenance of high dr...
Supersaturating drug delivery systems, such as amorphous solid dispersions (ASDs), have been used ex...
Poor water-solubility is a common characteristic of drug candidates in pharmaceutical development pi...
University of Minnesota Ph.D. dissertation. May 2016. Major: Pharmaceutics. Advisor: Raj Suryanaraya...
The preparation of amorphous solid dispersions (ASDs) has enabled the development of oral dosage for...
Poorly water-soluble drugs pose a significant challenge in developability due to poor oral absorptio...
The formulation of oral amorphous solid dispersions (ASD) includes the use of excipients to improve ...
Amorphous formulations, including amorphous solid dispersions (ASDs), consisting of the active pharm...
University of Minnesota Ph.D. dissertation.January 2018. Major: Pharmaceutics. Advisor: Raj Suryana...
University of Minnesota Ph.D. dissertation. October 2016. Major: Pharmaceutics. Advisor: Dr. Raj Sur...
Current drug discovery techniques tend to identify potential new drug entities with more complex str...
Many pharmaceutical compounds being developed in recent years are poorly soluble in water. This has ...
Amorphous drug delivery systems are increasingly utilized to enhance aqueous solubility and oral bio...
A major concern during formulation development has been to enhance the dissolution rate and bioavail...
Over the past few decades, amorphous solid dispersions (ASDs) have been of great interest to pharmac...
Polymers are often used to stabilize amorphous drug formulations enabling the maintenance of high dr...
Supersaturating drug delivery systems, such as amorphous solid dispersions (ASDs), have been used ex...
Poor water-solubility is a common characteristic of drug candidates in pharmaceutical development pi...
University of Minnesota Ph.D. dissertation. May 2016. Major: Pharmaceutics. Advisor: Raj Suryanaraya...
The preparation of amorphous solid dispersions (ASDs) has enabled the development of oral dosage for...
Poorly water-soluble drugs pose a significant challenge in developability due to poor oral absorptio...
The formulation of oral amorphous solid dispersions (ASD) includes the use of excipients to improve ...
Amorphous formulations, including amorphous solid dispersions (ASDs), consisting of the active pharm...